baber/WOPTO huggingface dataset:
Patent MX-2019001399-A (MX)
Title: Room temperature stable oral calcitonin formulation.
Inventor: JAMES P GILLIGAN
IPC: A61K9/20
Filed: 2017-08-03
Abstract: Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
Patent MX-2019002084-A (MX)
Title: Orienting magnetically-orientable flakes.
Inventor: VLADIMIR RAKSHA
IPC: B41M1/00
Filed: 2017-08-31
Abstract: According to examples, a substrate may be moved through a magnetic field, in which the substrate includes a fluid carrier containing magnetically-orientable flakes. The magnetic field may influence the magnetically-orientable flakes to be respectively oriented in one of multiple orientations. In addition, during movement of the substrate through the magnetic field, radiation may be applied onto a plurality of selected portions of the fluid carrier through at least one opening in a mask to cure the fluid carrier at the plurality of selected portions and fix the magnetically-orientable flakes in the plurality of selected portions at the respective angular orientations as influenced by the magnetic field.
Patent MX-2019002381-A (MX)
Title: Index matching layers.
Inventor: MICHAEL MARSHALL
IPC: G02B1/04
Filed: 2017-09-01
Abstract: Optical devices such as eyeglass lenses and digital displays having improved optical characteristics achieved, in part, through incorporation of an index matching system between material layers having different refractive indices.
Patent MX-2019003729-A (MX)
Title: A method of treating a material comprising an amine salt of a carboxylic acid having 4 to 10 carbon atoms.
Inventor: Tony Gough
IPC: D06P5/06
Filed: 2017-09-29
Abstract: A method of treating a material, the method comprising contacting the material with a composition comprising an amine salt of a carboxylic acid wherein the carboxylic acid has 4 to 10 carbon atoms.
Patent MX-2019004738-A (MX)
Title: Multi-phase oral composition for tooth whitening.
Inventor: PAUL ALBERT SAGEL
IPC: A61K8/22
Filed: 2017-10-23
Abstract: A multi-phase oral composition for whitening teeth.
Patent MX-2019005327-A (MX)
Title: Method for transmitting srs and terminal therefor.
Inventor: JONGHYUN PARK
IPC: H04W72/04
Filed: 2018-04-27
Abstract: A method for transmitting an SRS by a terminal may comprise the steps of: receiving, from a base station, first information including information on at least one predetermined SRS sequence parameter, which is set in association with a frequency hopping pattern, among SRS sequence parameters; generating an SRS sequence for the at least one predetermined SRS sequence parameter, using a value of a parameter corresponding to a frequency hopping pattern set in the terminal; and transmitting, through an SRS resource, the SRS to which the generated SRS sequence has been applied.
Patent MX-2019007115-A (MX)
Title: Novel recombinant protein uk 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours.
Inventor: ALBERTO BARTORELLI CUSANI
IPC: A61K38/16
Filed: 2017-12-14
Abstract: Disclosed is a novel recombinant protein UK 114 in stable polymer form for use in the treatment, diagnosis and prevention of malignant solid and systemic tumours.
Patent MX-2019008192-A (MX)
Title: Sensor for a wireless animal trap detection system.
Inventor: BYRON REID
IPC: A01M23/00
Filed: 2017-12-19
Abstract: An animal trap sensor includes a base having a distal end and a proximal end, a switch having a first metallic element and a second metallic element, and a signal unit, in which, when the first metallic element contacting the second metallic element, thereby forming a closed circuit, such that the signal unit transmits a signal to an off-site receiver. Or, an animal trap sensor includes a first portion and a second portion electrically connected with a signal unit including a power supply, in which, when the first and the second portions are disposed at a first distance between each other, thereby generating an output property, in which, when the first and the second portions are disposed at a second distance between each other, which is different from the first distance, thereby changing the output property and causing the signal unit to transmit a signal to an off-site receiver.
Patent MX-2019009029-A (MX)
Title: System and method for personalized virtual reality experience in a controlled environment.
Inventor: STEPHEN L HODGE
IPC: G06F21/32
Filed: 2018-01-30
Abstract: A system and method for initiating a personalized virtual reality session via a virtual reality communication system in a controlled environment is disclosed. The system includes a profile subsystem configured to store an inmate profile of the inmate of the controlled environment. The system also includes a virtual reality subsystem that retrieves the inmate profile associated with the inmate from the profile subsystem, initiates the virtual reality session involving a first communication device used by the inmate of the controlled environment, and personalizes the virtual reality session based on the inmate profile. The system also includes a communication subsystem configured to transmit information related to the virtual reality session to a monitoring system.
Patent MX-2019011004-A (MX)
Title: Compounds and compositions for intracellular delivery of therapeutic agents.
Inventor: KUMARASINGHE ELLALAHEWAGE SATHYAJITH
IPC: A61K47/24
Filed: 2018-03-15
Abstract: The disclosure features novel lipids and compositions involving the same. Nanoparticle compositions include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Nanoparticle compositions further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.
Patent MX-2019014748-A (MX)
Title: Low-dose brimonidine combinations and uses thereof.
Inventor: HORN GERALD
IPC: A61K9/08
Filed: 2018-06-07
Abstract: The present invention is directed to compositions containing low-dose brimonidine and either a second glaucoma drug, an anti-histamine or non-steroidal anti-inflammatory drug. The present invention is further directed to methods of treating glaucoma or allergies or reducing inflammation by administering compositions of the present invention.
Patent MX-2019015040-A (MX)
Title: Automated response server device, terminal device, response system, response method, and program.
Inventor: KIM MINSU
IPC: G06N5/04
Filed: 2018-06-07
Abstract: Provided is a response system for implementing an automated response in a chat while reducing the investment in a computer required for a learning process in artificial intelligence. A chat pattern generation unit of a terminal device generates chat pattern information corresponding to a pattern of input segments (which are inputs in a chat) and response segments (which are responses to the input segments). A learning processing unit carries out a learning process for a relationship between a response segment and input text corresponding to an input segment on the basis of the generated chat pattern, and outputs input interpretation-use knowledge data as the result of the learning process. A response-use knowledge data transmission unit transmits response-use knowledge data, which is based on response segments included in the chat pattern generated by the chat pattern generation unit, to an automated response server device. An input interpretation-use knowledge data transmission unit transmits the input interpretation-use knowledge data output from the learning processing unit to the automated response server device.
Patent MX-2020002153-A (MX)
Title: Surface cleaning apparatus with drying cycle.
Inventor: MILLER DAVID M
IPC: A47L11/30
Filed: 2020-02-25
Abstract: The present disclosure provides a surface cleaning apparatus that includes a recovery system that extracts liquid and debris with a drying cycle in which forced air flows through a recovery pathway of the recovery system to dry out components that remain wet and/or retain moisture after normal operation of the apparatus. The post-operation drying cycle can dry out components such as an agitator or brushroll, a brush chamber, a suction nozzle, a recovery tank, a filter, and any of the various conduits, ducts, and/or hoses fluidly coupling components of the recovery system together..
Patent MX-2020003484-A (MX)
Title: Methods and devices for performing an analytical measurement.
Inventor: LIMBURG BERND
IPC: G06T7/80
Filed: 2018-10-24
Abstract: EMPTY
Patent MX-2020003995-A (MX)
Title: Novel artificial nucleic acid molecules.
Inventor: SCHLAKE THOMAS
IPC: C12N15/67
Filed: 2018-10-17
Abstract: EMPTY
Patent MX-2020005680-A (MX)
Title: Angelman syndrome antisense treatment.
Inventor: DINDOT SCOTT VICTOR
IPC: A61K48/00
Filed: 2018-11-30
Abstract: Disclosed herein are antisense oligonucleotides that are capable of inducing expression of ubiquitin-protein ligase E3A (<i>UBE3A</i>) from the paternal allele in animal or human neurons. The oligonucleotides target the suppressor of the <i>UBE3A</i> paternal allele by hybridization to <i>SNHG14</i> long non-coding RNA at the 5'-end of <i>UBE3A-AS</i>, which is downstream of <i>SNORD115-45</i> snoRNA. Also disclosed are pharmaceutical compositions and methods for treatment of Angelman syndrome.
Patent MX-2020005905-A (MX)
Title: Sexed sperm bulk separation systems.
Inventor: KRUG KRISTIE
IPC: C12Q1/6879
Filed: 2018-11-09
Abstract: A process to bulk sex-select sperm which can involve such steps as: obtaining a subject sperm sample such as a collection of cells (1); inducing a sex-based differential alteration process for sperm in the sperm sample; presenting associationally active elements near the sperm within at least some of the sperm sample perhaps such as a fluid combination (4); causing such elements to differentially associate with at least portions of the elements based upon a sperm sex-based differential alteration state; acting on the elements together with their associated sperm through a separation modality (5) to bulk separate the sperm according to their differential sex-based properties. One type of associationally active element is potentially magnetic particles or differentially associatable particles (3) which may even be magnetic particles with inherent zeta potential charges that may associationally act and perhaps bind to an opposite zeta potential or other charges that the sperm may differentially acquire or achieve. This may present a method for magnetic separation of X-bearing and Y-bearing sperm perhaps such as having different charged membranes and perhaps such as after sialic acid activation.
Patent MX-2020011583-A (MX)
Title: Photographic method and system for aiding officials in locating an object.
Inventor: KOHLER DANIEL
IPC: G01B11/26
Filed: 2019-05-13
Abstract: A system and method for determining an absolute position of an object in an area is presented. The system includes a server having a processor, and a plurality of camera nodes coupled to the server. Each node includes a camera that acquires images of the object and area. The server receives image data from a camera, detects the object within an approximate location by image analysis techniques, and determines a relative position of the object in pixel coordinates. The processor then detects stationary markers proximate to the relative location of the object, determines an absolute position of the detected markers relative to known markers to define an absolute position of the marker, and determines an absolute location of the object in relation to the absolute location of the detected marker. This absolute position of the object is provided to an official to accurately locate the object in the area.
Patent MX-2020013010-A (MX)
Title: Egg-laying medium for insects, comprising a solid substrate.
Inventor: BEREZINA NATHALIE
IPC: A01K67/033
Filed: 2019-05-31
Abstract: The invention relates to the breeding of insects and more particularly to the separation of insect eggs from other constituents of an egg-laying medium. It relates to an egg-laying medium for insects, comprising at least 80% by weight of a solid substrate in the form of particles, at least 85% by weight of said particles having a size of less than 0.5 mm, wherein the weight percentage is given in relation to the total weight of the insect egg-laying medium. The invention also relates to a laying tray and uses thereof, particularly in a method for collecting insect eggs.
Patent MX-2020014221-A (MX)
Title: Tri-specific binding molecules and methods of use thereof.
Inventor: SHAH KALPANA
IPC: C07K16/18
Filed: 2016-11-24
Abstract: The present invention relates to Tri-Specific Binding Molecules, which are multichain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Binding Domains may be selected such that the Tri-Specific Binding Molecules are capable of binding to any three different epitopes. Such epitopes may be epitopes of the same antigen or epitopes of two or three different antigens. In a preferred embodiment, one of such epitopes will be capable of binding to CD3, the second of such epitopes will be capable of binding to CD8, and the third of such epitopes will be capable of binding to an epitope of a Disease-Associated Antigen. The invention also provides a novel RORl -binding antibody, as well as derivatives thereof and uses for such compositions.
Patent MX-2021000613-A (MX)
Title: Station steering profiles in a wireless network control system.
Inventor: LUMBATIS KURT ALAN
IPC: H04W84/12
Filed: 2019-08-22
Abstract: In a managed wireless environment where a controller is gathering data in order to optimize the wireless network, certain data parameters are gathered in order to optimize the network. The gathered parameters are then utilized to determine best case links for various attached wireless station devices in order to: 1) optimize the network and 2) optimize the per station (STA) links. The control points utilized to determine the network optimization will vary based on the desired outcomes for the system. As such, configurable 'profiles' will be utilized in order to prioritize outcomes for the system. These profiles may be utilized by the network steering controller in order to steer wireless station devices to optimize the network in the desired fashion.
Patent MX-2021000649-A (MX)
Title: Antenna monitoring for wireless and telecommunications for private, public, and first responders.
Inventor: LEAF FREDERICK DANIEL
IPC: H04B17/17
Filed: 2019-03-29
Abstract: This disclosure describes example antenna monitoring systems and methods that can include, among other things, a transmitter near each of the antennas in a distributed antenna system (DAS). The transmitter can transmit on a certain frequency or channel corresponding to that antenna, so that the various transmitters in the DAS each transmit on different frequencies. These frequencies can be detected by a receiver and can be processed to determine whether a signal at any frequency or channel expected to be received is missing. If any expected signal is missing for any frequency or channel, the receiver can infer that the antenna or a component associated with the antenna (such as cabling) may have failed. The receiver can then output an indication or notification that may be accessed by maintenance personnel and/or emergency personnel to enable them to identify and repair the non-functioning antenna or component.
Patent MX-2021000732-A (MX)
Title: Agent for treatment or prevention of htlv-1-associated myelopathy (ham), and ham treatment method.
Inventor: YAMANO YOSHIHISA
IPC: A61P25/00
Filed: 2019-07-19
Abstract: The present invention provides: an agent for the treatment or prevention of HTLV-1-associated myelopathy (HAM), the agent containing an RGMa inhibitor; and a HAM treatment method including the administration of a pharmacologically effective amount of an RGMa inhibitor to an HTLV-1-associated myelopathy (HAM) patient in need of the agent.
Patent MX-2021001992-A (MX)
Title: Cache warming: agility for a stateful service.
Inventor: MADAPPA SHASHI
Filed: 2019-11-25
Abstract: The disclosed computer-implemented method includes receiving an indication that cache data is to be copied from an originating cluster having a specified number of replica nodes to a destination cluster having an arbitrary number of replica nodes. The method further includes copying the cache data to a cache dump and creating a log that identifies where the cache data is stored in the cache dump. The method further includes copying the cache data from the cache dump to the replica nodes of the destination cluster. The copying includes writing the copied data in a distributed manner, such that at least a portion of the copied data is distributed over each of the replica nodes in the destination cluster. Various other methods, systems, and computer-readable media are also disclosed.
Patent MX-2021006102-A (MX)
Title: Improved delivery of large agents.
Inventor: EDELSON JONATHAN
IPC: A61K9/107
Filed: 2019-11-26
Abstract: Methods, compositions, and devices for enhancing transdermal delivery and/or bioavailability of large agents.
Patent MX-2021007904-A (MX)
Title: Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device.
Inventor: IMRAN MIR
IPC: A61K9/14
Filed: 2019-12-31
Abstract: Embodiments of the invention provide swallowable devices, preparations and methods for delivering therapeutic agents (TA) within the GI tract. Many embodiments provide a swallowable device such as a capsule for delivering TAs into the intestinal wall (IW) or other GI location. Embodiments also provide various TA preparations such as IgG that are configured to be contained within the capsule, advanced from the capsule into the IW and degrade to release the TA into the bloodstream where they exhibit a selected plasma concentration profile which may have selected pharmacokinetic parameters. The preparation can be operably coupled to a delivery means having a first configuration where the preparation is contained in the capsule and a second configuration where the preparation is advanced out of the capsule into the IW. Embodiments of the invention are particularly useful for the delivery of drugs which are poorly absorbed, tolerated and/or degraded within the GI tract.
Patent MX-2021008009-A (MX)
Title: Alk5 inhibitors for treating myelodysplastic syndrome.
Inventor: WARNER STEVEN L
IPC: A61K31/453
Filed: 2020-01-10
Abstract: Described herein are methods for treating ALK5-mediated disease including myelodysplastic syndrome (MDS), anemia and anemia of chronic disease. Also provided are methods of inhibiting ALK5.
Patent MX-2021009727-A (MX)
Title: Antibodies that bind tumor tissue, and their diagnostic and therapeutic uses.
Inventor: ROBINSON WILLIAM H
IPC: C07K16/06
Filed: 2020-02-14
Abstract: Provided herein are antibodies that bind to tumor tissue through a binding interaction with an extracellular RNA-protein complex. Such antibodies are used in methods of inducing an immune response and methods of inhibiting tumor cell growth. Additionally provided are methods of producing such antibodies.
Patent MX-2021010114-A (MX)
Title: Methods of treating ocular cancer using anti-met antibodies and bispecific antigen binding molecules that bind met.
Inventor: SCHWARTZ GARY
IPC: A61K31/537
Filed: 2020-02-20
Abstract: Provided herein are methods of treating ocular cancer such as uveal melanoma, orbital lymphoma, retinoblastoma, and medulloepithelioma using antibodies and bispecific antigen-binding molecules that bind MET or antibody-drug conjugates (ADCs) comprising the antibodies or bispecific antigen-binding molecules. The bispecific antigen-binding molecules comprise a first and a second antigen-binding domain, wherein the first and second antigen-binding domains bind to two different epitopes of the extracellular domain of human MET. The ADCs comprise the antibodies or bispecific antigen-binding molecules provided herein linked to a cytotoxic agent, radionuclide, or other moiety. The antibodies and bispecific antigen-binding molecules are capable of blocking the interaction between human MET and its ligand HGF. A subject having ocular cancer, for example, an uveal melanoma expressing c-Met, can be treated by administering to the subject an antibody, a bispecific antigen-binding molecule, or an ADC thereof.
Patent MX-2021010744-A (MX)
Title: Methods for the treatment of perimenopause and menopause.
Inventor: LOYA CARLOS
IPC: A61K31/575
Filed: 2020-03-04
Abstract: The invention relates to methods of treating the symptoms of perimenopause or menopause using positive allosteric modulators Î³-aminobutyric acid type A (GABA-A PAMs) receptor, including 3Î±-hydroxy-3Î²-methoxymethyl-21-(1'-imidazolyl)-5Î±-pregnan-20 -one and salts thereof.
Patent MX-2021011560-A (MX)
Title: Stainless seamless steel pipe.
Inventor: YUGA MASAO
IPC: C22C38/00
Filed: 2020-02-28
Abstract: Provided is a stainless seamless steel pipe having high strength and excellent low-temperature toughness and corrosion resistance.ãA stainless seamless steel pipe which has a composition containing, in terms of % by mass, 0.06% or less of C, 1.0% or less of Si, 0.01 to 1.0% inclusive of Mn, 0.05% or less of P, 0.005% or less of S, 14.0 to 17.0% inclusive of Cr, more than 3.80% and 6.0% or less of Mo, more than 1.03% and 3.5% or less of Cu, 3.5 to 6.0% inclusive of Ni, 0.10% or less of Al, 0.10% or less of N and 0.010% or less of O, and also containing C, Si, Mn, Cr, Ni, Mo, Cu and N in amounts that satisfy a specified relational expression, with the remainder made up by Fe and unavoidable impurities, has a structure containing, in terms of volume ratios, 40% or more of a martensite phase, 60% or less of a ferrite phase and 30% or less of a retained austenite phase, and also has yield strength of 862 MPa or more.
Patent MX-2021013929-A (MX)
Title: Non-contact electronic cigarette heater.
Inventor: ZHU XIAOHUA
IPC: A24F47/00
Filed: 2020-05-14
Abstract: A non-contact electronic cigarette heater, comprising a ceramic heating body (10) and a smoke-producing product bearing assembly (20). The ceramic heating body (10) comprises a heating main body (11) and a heating circuit (12), the heating main body (11) taking a columnar shape, and a porous channel (101) being provided inside the heating main body (11). The heating circuit (12) is provided on the heating main body (11) so as to heat air passing through the porous channel (101). The smoke-producing product bearing assembly (20) comprises a pre-heating pipe (21) and a blocking piece (22), the blocking piece (22) being arranged in a chamber defined by the pre-heating pipe (21) so as to divide the chamber into a first chamber and a second chamber. The first chamber is suitable for placing a smoke-producing product, and pre-heats the smoke-producing product, and the second chamber is suitable for placing at least a portion of the the ceramic heating body (10). By means of placing at least a portion of the ceramic heating body (10) in the chamber defined by the pre-heating pipe, the effect of a pre-heating chamber can be achieved, raising heating efficiency, and causing flowing air being heated to heat the smoke-producing product evenly, preventing tobacco in the smoke-producing product from being wasted, and further being able to improve and increase the amount of smoke.